[Federal Register Volume 71, Number 41 (Thursday, March 2, 2006)]
[Notices]
[Page 10728]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 06-1952]



[[Page 10728]]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 1-11394]


Issuer Delisting; Notice of Application of MEDTOX Scientific, 
Inc. To Withdraw Its Common Stock, $.15 Par Value, From Listing and 
Registration on the American Stock Exchange LLC

February 24, 2006.
    On February 9, 2006, MEDTOX Scientific, Inc., a Delaware 
corporation (``Issuer''), filed an application with the Securities and 
Exchange Commission (``Commission''), pursuant to section 12(d) of the 
Securities Exchange Act of 1934 (``Act'') \1\ and Rule 12d2-2(d) 
thereunder,\2\ to withdraw its common stock, $.15 per value 
(``Security''), from listing and registration on the American Stock 
Exchange LLC (``Amex'')
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 781(d).
    \2\ 17 CFR 240.12d-2(d).
---------------------------------------------------------------------------

    On February 7, 2006, the Board of Directors (``Board'') of the 
Issuer unanimously approved a resolution with the Security from Amex 
and to list the Security on the Nasdaq National Market (``Nasdaq''). 
The Issuer stated it believes Nasdaq will not only provide more 
recognition for the Issuer in the investment community, but increase 
liquidity and enhance value for shareholders. The Issuer stated that it 
anticipates the Security to trade on Nasdaq on February 16, 2006.
    The Issuer stated in its application that it has met the 
requirements of Amex Rule 18 by complying with all applicable laws in 
effect in the State of Delaware, in which it is incorporated, and 
provided written notice of withdrawal to Amex.
    The Issuer's application relates solely to withdrawal of the 
Security from listing on Amex and from registration under section 12(b) 
of the Act,\3\ and shall not affect its obligation to be registered 
under section 12(g) of the Act.\4\
---------------------------------------------------------------------------

    \3\ 15 U.S.C. 78l(b).
    \4\ 15 U.S.C. 78l(g).
---------------------------------------------------------------------------

    Any interested person may, on or before March 22, 2006, comment on 
the facts bearing upon whether the application has been made in 
accordance with the rules of Amex, and what terms, if any, should be 
imposed by the Commission for the protection of investors. All comment 
letters may be submitted by either of the following methods:

Electronic Comments

     Use the Commission's Internet comment from (http://www.sec.gov/rules/delist.shtml); or
     Send an e-mail to [email protected]. Please include 
the File Number 1-11394 or;

Paper Comments

     Send paper comments in triplicate to Nancy M. Morris, 
Secretary, Securities and Exchange Commission, 100 F Street, NE., 
Washington, DC 20549-1090.
    All submissions should refer to File Number 1-11394. This file 
number should be included on the subject line if e-mail is used. To 
help us process and review your comments more efficiently, please use 
only one method. The Commission will post all comments on the 
Commission's Internet Web site (http://www.sec.gov/rules/delist.shtml). 
Comments are also available for public inspection and copying in the 
Commission's Public Reference Room. All comments received will be 
posted without change; we do not edit personal identifying information 
from submissions. You should submit only information that you wish to 
make available publicly.
    The Commission, based on the information submitted to it, will 
issue an order granting the application after the date mentioned above, 
unless the Commission determines to order a hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.\5\
---------------------------------------------------------------------------

    \5\ 17 CFR 200.30-3(a)(1).
---------------------------------------------------------------------------

Nancy M. Morris,
Secretary.
[FR Doc. 06-1952 Filed 3-1-06; 8:45am]
BILLING CODE 8010-01-M